Randomized phase II trial of sipuleucel-T immunotherapy preceded by sensitizing radiation therapy and sipuleucel-t alone in patients with metastatic castrate resistant prostate cancer.
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Przemyslaw Twardowski, Jeffrey Y.C. Wong, Sumanta K. Pal, Paul Henry Frankel, Kelly Franklin, Maribel Junqueira, Manisha R. Prajapati, Deborah Harwood, Neeraj Agarwal
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2600733125
